The Pharma Podcast Wed, 25 Mar 2026 06:03:37 -0400 http://www.thepharmapodcast.ca en-us © 2026 The Pharma Podcast yes 423ccc40-00bd-5d5e-b418-978d0e51a091 Sam Tarantino episodic false Buzzsprout (https://www.buzzsprout.com) Pharmaceutical, Pharma, Biotechnology, Biotech, vaccine, Medical Technology, Medtech, Canada, Distributor, Import, consultant, Sam Tarantino https://storage.buzzsprout.com/dl98m4hv5fbew6vb48mj0zh01gnc?.jpg The Pharma Podcast http://www.thepharmapodcast.ca Rare Voices: Navigating Life with Uncommon Courage in Canada Rare Voices: Navigating Life with Uncommon Courage in Canada On this special episode of the Pharma Podcast, we're honouring Rare Disease Month this February by delving into the personal and profound stories from the front lines of rare diseases in Canada. Our focus is on the unique challenges, healthcare experiences, and the resilience required to navigate life with a rare condition. In celebration of this important month, I’m thrilled to have Dr. Sonia Rehal with us. Sonia is not only courageously living with a rare disease but also actively participating in raising awareness and advocating for better support and research for rare diseases in Canada.

Sonia's journey offers us a window into the day-to-day realities faced by individuals with rare diseases, from the quest for diagnosis to access to specialised care, and underscores the importance of community support. Her insights are invaluable in dispelling misconceptions about rare diseases and highlighting the ongoing efforts to improve the lives of those affected.

Join us as we explore Sonia's story, the broader landscape of rare diseases in Canada, and what hope and advancements lie on the horizon for patients and their families. 

Through this episode, we hope to convey a powerful message: while each rare disease may affect a small number of individuals, collectively, these conditions are not that rare at all. 

Lipodystrophy Canada Website:

https://lipodystrophy-canada-foundation.wiredwebsites.org/

 

Facebook Page:

https://www.facebook.com/profile.php?id=100092509705779

 

Our Email address: 

lipodystrophycanada@gmail.com



]]> On this special episode of the Pharma Podcast, we're honouring Rare Disease Month this February by delving into the personal and profound stories from the front lines of rare diseases in Canada. Our focus is on the unique challenges, healthcare experiences, and the resilience required to navigate life with a rare condition. In celebration of this important month, I’m thrilled to have Dr. Sonia Rehal with us. Sonia is not only courageously living with a rare disease but also actively participating in raising awareness and advocating for better support and research for rare diseases in Canada.

Sonia's journey offers us a window into the day-to-day realities faced by individuals with rare diseases, from the quest for diagnosis to access to specialised care, and underscores the importance of community support. Her insights are invaluable in dispelling misconceptions about rare diseases and highlighting the ongoing efforts to improve the lives of those affected.

Join us as we explore Sonia's story, the broader landscape of rare diseases in Canada, and what hope and advancements lie on the horizon for patients and their families. 

Through this episode, we hope to convey a powerful message: while each rare disease may affect a small number of individuals, collectively, these conditions are not that rare at all. 

Lipodystrophy Canada Website:

https://lipodystrophy-canada-foundation.wiredwebsites.org/

 

Facebook Page:

https://www.facebook.com/profile.php?id=100092509705779

 

Our Email address: 

lipodystrophycanada@gmail.com



]]> https://www.thepharmapodcast.ca/ Sam Tarantino / Sonia Rehal Buzzsprout-14520626 Sat, 17 Feb 2024 08:00:00 -0500 1896 Rare disorders, Rare disease day, PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 5 2 full false Florida’s Prescription for Change: The Impact of Florida’s Move to Import Canadian Drugs! Florida’s Prescription for Change: The Impact of Florida’s Move to Import Canadian Drugs! On this episode of the PharmaPodcast, we will discuss Florida, and its plans to import Drugs from Canada.  Florida is making headlines for its bold move to import prescription drugs from Canada, a strategy aimed at reducing healthcare costs in that state. This shift could potentially transform the landscape of pharmaceutical importation in the US and set a precedent for other states.

To help us better understand this complex and fascinating topic, I’m thrilled to have DANI Peters with us.  Dani is President of Magnet Strategy Group Inc.  and Special Advisor at the Alliance for Safe Online Pharmacy Canada. Dani is an expert in healthcare policy and has been closely following the developments in drug importation policies.

Contact Details for Dani Peters:
 www.buysaferx.pharmacy/canada
dani.peters@buysaferx.pharmacy

 


]]> On this episode of the PharmaPodcast, we will discuss Florida, and its plans to import Drugs from Canada.  Florida is making headlines for its bold move to import prescription drugs from Canada, a strategy aimed at reducing healthcare costs in that state. This shift could potentially transform the landscape of pharmaceutical importation in the US and set a precedent for other states.

To help us better understand this complex and fascinating topic, I’m thrilled to have DANI Peters with us.  Dani is President of Magnet Strategy Group Inc.  and Special Advisor at the Alliance for Safe Online Pharmacy Canada. Dani is an expert in healthcare policy and has been closely following the developments in drug importation policies.

Contact Details for Dani Peters:
 www.buysaferx.pharmacy/canada
dani.peters@buysaferx.pharmacy

 


]]> https://www.thepharmapodcast.ca/ Sam Tarantino / Dani Peters Buzzsprout-14371590 Wed, 24 Jan 2024 15:00:00 -0500 1785 #florida, #Canada, #PharmaPodcast, #GlobalHealthImpact, #HPICLeadership, #HealthPartnersInternational, #PharmaceuticalPartnerships, #HealthcareHeroes, #GlobalHealthcare, #MedicalMissions, #HealthForAll, #SavingLivesWorldwide 5 1 full false A Year of Healing: Impact and Insights with Lois Brown from Health Partners International Canada A Year of Healing: Impact and Insights with Lois Brown from Health Partners International Canada On this episode of the Pharma Podcast, my guest is Lois Brown, President of Health Partners International Canada, and on this episode of the Pharma Podcast, we discuss the transformative impact of global health initiatives, the critical role of pharmaceutical partnerships in advancing healthcare worldwide, and the inspiring achievements and future goals of HPIC in its mission to improve health and save lives.

HPIC is now working in 39 countries including our latest emergency response to support victims in Israel and Gaza.

https://hpicanada.ca/donate/



]]> On this episode of the Pharma Podcast, my guest is Lois Brown, President of Health Partners International Canada, and on this episode of the Pharma Podcast, we discuss the transformative impact of global health initiatives, the critical role of pharmaceutical partnerships in advancing healthcare worldwide, and the inspiring achievements and future goals of HPIC in its mission to improve health and save lives.

HPIC is now working in 39 countries including our latest emergency response to support victims in Israel and Gaza.

https://hpicanada.ca/donate/



]]> https://www.thepharmapodcast.ca/ Sam Tarantino / Lois Brown Buzzsprout-14180602 Wed, 20 Dec 2023 12:00:00 -0500 1665 #PharmaPodcast, #GlobalHealthImpact, #HPICLeadership, #HealthPartnersInternational, #PharmaceuticalPartnerships, #HealthcareHeroes, #GlobalHealthcare, #MedicalMissions, #HealthForAll, #SavingLivesWorldwide 4 7 full false Data Unleashed: Unmasking the Real World Evidence Revolution Data Unleashed: Unmasking the Real World Evidence Revolution On this episode of the PharmaPodcast, my guest is Tara Cowling, President and Managing Principal at Medlior Health Outcomes Research. Tara is a leader in Real World Evidence, HTA (Health Technology Assessments) and Outcomes Research.

We delve into the pivotal role of Real World Evidence (RWE) in drug reimbursement and market access.  Join us as we explore the significance of peripheral services like Patient Support Programs and speciality pharmacies in generating crucial Real World Data and shaping healthcare decisions.

Tara shares invaluable insights on how we can bridge the gap between real-world experiences and compelling Real World Evidence.  Together, we'll tackle historical concerns, biases, and data quality issues, discovering innovative ways to overcome these challenges.

Contact Details:

Tara Cowling, MA (Oxon), MSc (she/her)

President and Managing Principal
https://www.medlior.com/

Suite 300 – 160 Quarry Park Blvd SE

Calgary, Alberta T2C 3G3

1-403-460-2616

info@medlior.com

]]> On this episode of the PharmaPodcast, my guest is Tara Cowling, President and Managing Principal at Medlior Health Outcomes Research. Tara is a leader in Real World Evidence, HTA (Health Technology Assessments) and Outcomes Research.

We delve into the pivotal role of Real World Evidence (RWE) in drug reimbursement and market access.  Join us as we explore the significance of peripheral services like Patient Support Programs and speciality pharmacies in generating crucial Real World Data and shaping healthcare decisions.

Tara shares invaluable insights on how we can bridge the gap between real-world experiences and compelling Real World Evidence.  Together, we'll tackle historical concerns, biases, and data quality issues, discovering innovative ways to overcome these challenges.

Contact Details:

Tara Cowling, MA (Oxon), MSc (she/her)

President and Managing Principal
https://www.medlior.com/

Suite 300 – 160 Quarry Park Blvd SE

Calgary, Alberta T2C 3G3

1-403-460-2616

info@medlior.com

]]> https://www.thepharmapodcast.ca/ Tara Cowling / Sam Tarantino Buzzsprout-13320582 Mon, 31 Jul 2023 09:00:00 -0400 3066 #RealWorldEvidence #HealthcarePodcast #DataInnovation #DrugReimbursement #MarketAccess #PatientSupportPrograms #SpecialtyPharmacy #HealthcareInsights #InformedDecisionMaking #DataAnalytics #EthicalHealthcare #PodcastLaunch #HealthcareInnovation #DataDrive 4 6 full false Unlocking the Mind: Exploring Psilocybin's Potential for Healing PTSD and Enhancing Brain Health Unlocking the Mind: Exploring Psilocybin's Potential for Healing PTSD and Enhancing Brain Health On this episode of the PharmaPodcast, my guest is Greg Rutherford, Chief Commercial Officer at  Apex Labs, a Vancouver based patient driven pharmaceutical company that develops and commercialises clinically evaluated psilocybin-derived treatments to tackle the most critical unmet need in depression, anxiety, and PTSD among Veterans and the general public.

Greg and I will delve into the fascinating world of Psilocybin and its remarkable potential to aid patients with PTSD while promoting overall brain health. Join us as we explore the science behind Psilocybin, its effects on the brain, and the emerging research supporting its therapeutic benefits. Our expert guest will discuss the rationale for using Psilocybin in PTSD treatment, highlight key findings from clinical studies, and shed light on how Psilocybin therapy differs from traditional approaches. We'll also address the potential risks, legal considerations, and the importance of public and professional education. Tune in to learn about the promising possibilities of Psilocybin as we uncover its role in unlocking the mind for healing and well-being.

]]> On this episode of the PharmaPodcast, my guest is Greg Rutherford, Chief Commercial Officer at  Apex Labs, a Vancouver based patient driven pharmaceutical company that develops and commercialises clinically evaluated psilocybin-derived treatments to tackle the most critical unmet need in depression, anxiety, and PTSD among Veterans and the general public.

Greg and I will delve into the fascinating world of Psilocybin and its remarkable potential to aid patients with PTSD while promoting overall brain health. Join us as we explore the science behind Psilocybin, its effects on the brain, and the emerging research supporting its therapeutic benefits. Our expert guest will discuss the rationale for using Psilocybin in PTSD treatment, highlight key findings from clinical studies, and shed light on how Psilocybin therapy differs from traditional approaches. We'll also address the potential risks, legal considerations, and the importance of public and professional education. Tune in to learn about the promising possibilities of Psilocybin as we uncover its role in unlocking the mind for healing and well-being.

]]> https://www.thepharmapodcast.ca/ Sam Tarantino / Greg Rutherford Buzzsprout-13103175 Mon, 26 Jun 2023 08:00:00 -0400 1604 #Psilocybin, #PTSD, #BrainHealth, #MentalHealth, #TherapeuticPotential, #Psychedelics, #HealingJourney, #Mindfulness, #Research, #Wellbeing, #HolisticHealth, #ConsciousnessExpansion, #AlternativeTherapy, #PodcastEpisode, #PodcastRecommendation, PMPRB, Dru 4 5 full false Ukraine - Starting and Running a Business in Difficult Circumstances Ukraine - Starting and Running a Business in Difficult Circumstances On this episode of the PharmaPodcast, I have an extra special guest. Artem Brytchenko is CEO at Platforce, a company based in Ukraine that he continues to run, in spite of all the adversity he is facing during a time of war.  I’m sure you will find this interview not just informative, but also Inspirational.

Contact Information:

Artem Brytchenko 

Chief Executive Officer | Platforce

E:  support@platforce.io

W: https://platforce.io/

]]> On this episode of the PharmaPodcast, I have an extra special guest. Artem Brytchenko is CEO at Platforce, a company based in Ukraine that he continues to run, in spite of all the adversity he is facing during a time of war.  I’m sure you will find this interview not just informative, but also Inspirational.

Contact Information:

Artem Brytchenko 

Chief Executive Officer | Platforce

E:  support@platforce.io

W: https://platforce.io/

]]> http://www.thepharmapodcast.ca Sam Tarantino / Artem Brytchenko Buzzsprout-12533529 Tue, 28 Mar 2023 11:00:00 -0400 1204 Ukraine, Rare disorders, Rare disease day, PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 4 4 full false Dr. Durhane Wong-Rieger - Bringing awareness to Rare Disease Day Dr. Durhane Wong-Rieger - Bringing awareness to Rare Disease Day On this episode of the Pharma Podcast, my extra-special guest is Dr. Durhane Wong-Rieger,  President & CEO at Canadian Organization for Rare Disorders.

To mark Rare Disease Day, which we celebrate on the last day of February, I can think of no better guest than Dr. Durhane Wong-Rieger to bring awareness to Rare Disease Day.

She also gives a great overview of CORD and its mission.

To learn more about CORD, upcoming events, or to make a donation, please visit: www.raredisorders.ca

You can also follow CORD on social media:

https://www.facebook.com/RareDisorders

https://twitter.com/raredisorders

https://www.youtube.com/user/CORDRareDisorders





 

]]> On this episode of the Pharma Podcast, my extra-special guest is Dr. Durhane Wong-Rieger,  President & CEO at Canadian Organization for Rare Disorders.

To mark Rare Disease Day, which we celebrate on the last day of February, I can think of no better guest than Dr. Durhane Wong-Rieger to bring awareness to Rare Disease Day.

She also gives a great overview of CORD and its mission.

To learn more about CORD, upcoming events, or to make a donation, please visit: www.raredisorders.ca

You can also follow CORD on social media:

https://www.facebook.com/RareDisorders

https://twitter.com/raredisorders

https://www.youtube.com/user/CORDRareDisorders





 

]]> https://www.thepharmapodcast.ca/ Sam Tarantino / Durhane Wong-Rieger Buzzsprout-12259928 Wed, 15 Feb 2023 11:00:00 -0500 2892 Rare disorders, Rare disease day, PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 4 3 full false The NEAR Future of Regenerative medicine The NEAR Future of Regenerative medicine On this episode of the Pharma Podcast, my guest is  Dr, Drew Taylor, founder and CEO of ACORN BIOLABS.

As an entrepreneur and regenerative medicine pioneer, Drew is making breakthrough medicine accessible for everyday people. After simultaneously earning a PhD in Biomedical Engineering at the University of Toronto and playing professional baseball, Drew worked as part of Mount Sinai Hospital’s Bio-engineering of Skeletal Tissues Team, then as Chief Science Officer at Epic Capital Management. 

In 2017, Drew co-founded Acorn Biolabs, to help more people access the future of regenerative medicine by providing affordable, accessible, and non-invasive cell banking.


Drew and I discuss his journey to entrepreneurship, and the NEAR FUTURE of Regenerative medicine.


Contact Information:

Drew Taylor, MSc, PhD

Chief Executive Officer | Acorn Biolabs Inc.

E: info@acorn.me

W: acorn.me
Instagram: @drdrewtaylor

Save your cells from aging.
Join our waitlist | Sign-up for the newsletter

]]> On this episode of the Pharma Podcast, my guest is  Dr, Drew Taylor, founder and CEO of ACORN BIOLABS.

As an entrepreneur and regenerative medicine pioneer, Drew is making breakthrough medicine accessible for everyday people. After simultaneously earning a PhD in Biomedical Engineering at the University of Toronto and playing professional baseball, Drew worked as part of Mount Sinai Hospital’s Bio-engineering of Skeletal Tissues Team, then as Chief Science Officer at Epic Capital Management. 

In 2017, Drew co-founded Acorn Biolabs, to help more people access the future of regenerative medicine by providing affordable, accessible, and non-invasive cell banking.


Drew and I discuss his journey to entrepreneurship, and the NEAR FUTURE of Regenerative medicine.


Contact Information:

Drew Taylor, MSc, PhD

Chief Executive Officer | Acorn Biolabs Inc.

E: info@acorn.me

W: acorn.me
Instagram: @drdrewtaylor

Save your cells from aging.
Join our waitlist | Sign-up for the newsletter

]]> https://www.thepharmapodcast.ca/ Drew Taylor Buzzsprout-12037409 Fri, 13 Jan 2023 12:00:00 -0500 1637 entrepreneurship, Regenerative medicine, PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 4 2 full false CPOINT CAPITAL - How a Changing Economy is Affecting Investor Appetites CPOINT CAPITAL - How a Changing Economy is Affecting Investor Appetites Welcome to the Pharma Podcast, conversations with industry experts and business leaders about important and current topics in Canadian pharma, biotech and medtech.

On this episode of the PharmaPodcast, my guest is  Jesse Buckstein, Principle at CPoint Capital

Jesse and I discuss the Healthcare investment market in Canada - How a changing economy is affecting investor appetites.


Contact Information for Jesse:

CPOINT Capital
512-555 Richmond Street West, Toronto, ON, M5V 3B1
T: +1 905 881 4440 x 203 | M: +1 647 981 4293 | F: +1 647 847 9055
E: jesse@cpointcapital.ca | W: www.cpointcapital.com

]]> Welcome to the Pharma Podcast, conversations with industry experts and business leaders about important and current topics in Canadian pharma, biotech and medtech.

On this episode of the PharmaPodcast, my guest is  Jesse Buckstein, Principle at CPoint Capital

Jesse and I discuss the Healthcare investment market in Canada - How a changing economy is affecting investor appetites.


Contact Information for Jesse:

CPOINT Capital
512-555 Richmond Street West, Toronto, ON, M5V 3B1
T: +1 905 881 4440 x 203 | M: +1 647 981 4293 | F: +1 647 847 9055
E: jesse@cpointcapital.ca | W: www.cpointcapital.com

]]> https://www.thepharmapodcast.ca/ Jesse Buckstein Buzzsprout-11461499 Sat, 08 Oct 2022 08:00:00 -0400 1084 PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, investing, investment 4 1 full false Bloom Burton - Healthcare Investment Market in Canada Bloom Burton - Healthcare Investment Market in Canada Welcome to the Pharma Podcast, conversations with industry experts and business leaders about important and current topics in Canadian pharma, biotech and medtech.

On this episode of the PharmaPodcast, my guest is Brian Bloom, CEO, Bloom Burton

On the heels of the Bloom Burton Healthcare Investor Conference, which was held in Toronto on May 2-3, Brian and I will discuss the latest developments in Canadian healthcare companies.

Contact Information for Bloom Burton:
reception@bloomburton.com
https://www.bloomburton.com/contact-us/

]]> Welcome to the Pharma Podcast, conversations with industry experts and business leaders about important and current topics in Canadian pharma, biotech and medtech.

On this episode of the PharmaPodcast, my guest is Brian Bloom, CEO, Bloom Burton

On the heels of the Bloom Burton Healthcare Investor Conference, which was held in Toronto on May 2-3, Brian and I will discuss the latest developments in Canadian healthcare companies.

Contact Information for Bloom Burton:
reception@bloomburton.com
https://www.bloomburton.com/contact-us/

]]> Brian Bloom Buzzsprout-10672782 Tue, 24 May 2022 09:00:00 -0400 2194 PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 3 2 full false Health Partners International of Canada's Emergency Response to UKRAINE Health Partners International of Canada's Emergency Response to UKRAINE Support Health Partners Ukraine Relief efforts

On this episode of the PharmaPodcast my guest is Lois Brown, President of Health Partners International  of Canada.  Lois and I discuss Health Partners and its response to the Emergency in Ukraine.

Health Partners is actively responding to the crisis in Ukraine by providing Humanitarian Medical Kits to Ukrainians in-country and in neighbouring refugee camps.

Over the next few months, Health Partners aims to send 400 Humanitarian Medical Kits to provide urgently-needed medical relief, and need to raise $240,000 in order to mobilize these medicines.

Please support our efforts by making a donation to our ‘Ukraine Emergency Fund’ today.

https://hpicanada.ca/donate/

]]> Support Health Partners Ukraine Relief efforts

On this episode of the PharmaPodcast my guest is Lois Brown, President of Health Partners International  of Canada.  Lois and I discuss Health Partners and its response to the Emergency in Ukraine.

Health Partners is actively responding to the crisis in Ukraine by providing Humanitarian Medical Kits to Ukrainians in-country and in neighbouring refugee camps.

Over the next few months, Health Partners aims to send 400 Humanitarian Medical Kits to provide urgently-needed medical relief, and need to raise $240,000 in order to mobilize these medicines.

Please support our efforts by making a donation to our ‘Ukraine Emergency Fund’ today.

https://hpicanada.ca/donate/

]]> https://www.thepharmapodcast.ca/ Sam Tarantino Buzzsprout-10241680 Sun, 13 Mar 2022 16:00:00 -0400 1176 Ukraine, donate, Health Partners, pharma 3 1 full false Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?” Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?” On this episode of The Pharma Podcast, my guest is Raj Indupuri, CEO, eClinical Solutions. 

Raj  and I explore the Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?” 

Contact Information:
Raj Indupuri
CEO
eClinical Solutions
rindupuri@eclinicalsol.com
tel. 508.594.6313


]]> On this episode of The Pharma Podcast, my guest is Raj Indupuri, CEO, eClinical Solutions. 

Raj  and I explore the Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?” 

Contact Information:
Raj Indupuri
CEO
eClinical Solutions
rindupuri@eclinicalsol.com
tel. 508.594.6313


]]> Raj Indupuri Buzzsprout-8875309 Fri, 16 Jul 2021 13:00:00 -0400 1552 CRO, Clinical Research, PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 2 8 full false Current Commercial Landscape for Pharma in Canada Current Commercial Landscape for Pharma in Canada On this episode of the PharmaPodcast my guest is Michael Cloutier,  founding partner at Accelera Canada.   Mike has been CEO/President/GM of seven Canadian companies and affiliates including: Searle, Pharmacia, AstraZeneca, COTI, InterMune, PTC Therapeutics, Diabetes Canada! 

Mike and I discuss the current commercial landscape for pharma in Canada, including its challenges and opportunities.

Contact Information:
Michael Cloutier
Founding Partner
michael.cloutier@acceleracanada.com
289-208-4191

210B-219 Dufferin Street,
Toronto, ON M6K 3J1

]]> On this episode of the PharmaPodcast my guest is Michael Cloutier,  founding partner at Accelera Canada.   Mike has been CEO/President/GM of seven Canadian companies and affiliates including: Searle, Pharmacia, AstraZeneca, COTI, InterMune, PTC Therapeutics, Diabetes Canada! 

Mike and I discuss the current commercial landscape for pharma in Canada, including its challenges and opportunities.

Contact Information:
Michael Cloutier
Founding Partner
michael.cloutier@acceleracanada.com
289-208-4191

210B-219 Dufferin Street,
Toronto, ON M6K 3J1

]]> Michael Cloutier Buzzsprout-8534113 Mon, 17 May 2021 09:00:00 -0400 697 PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 2 7 full false Do BioSimilars Need a Patient Support Program? Do BioSimilars Need a Patient Support Program? On this episode of the Pharma Podcast my guest is Nicole Serena, President and Managing Director at PSPConsult, a division of Waldron & Associates and co-founder of PSPCertify – a new Certification Program for PSP Professionals. 

Nicole and I discuss BioSimilars and the need for Patient Support Programs to support them.   

Contact Information:
Nicole Serena
President & Managing Director PSPConsult
A division of Waldron & Associates
nicole@pspconsult.ca
www.pspconsult.ca

]]> On this episode of the Pharma Podcast my guest is Nicole Serena, President and Managing Director at PSPConsult, a division of Waldron & Associates and co-founder of PSPCertify – a new Certification Program for PSP Professionals. 

Nicole and I discuss BioSimilars and the need for Patient Support Programs to support them.   

Contact Information:
Nicole Serena
President & Managing Director PSPConsult
A division of Waldron & Associates
nicole@pspconsult.ca
www.pspconsult.ca

]]> http://thepharmapodcast.ca Nicole Serena Buzzsprout-8273801 Mon, 05 Apr 2021 08:00:00 -0400 807 patient support, PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 2 6 full false CADTH - Streamlined Input Processes for Patients and Clinicians CADTH - Streamlined Input Processes for Patients and Clinicians Ryan Clarke is CEO and founder of Advocacy Solutions and a Senior Partner at Accelera Canada, where he is responsible for Advocacy & Stakeholder Relations.

In this episode of The Pharma Podcast Ryan discusses CADTH (Canadian Agency for Drugs and Technologies in Health)  and the streamlined input processes for both patients and Clinicians.

Contact Information:
ryan.clarke@acceleracanada.com

C: 416.919.9532 
Toll Free: 1.800.250.1569
219 Dufferin Street, Unit 210B, Toronto ON, M6K 3J1

 

]]> Ryan Clarke is CEO and founder of Advocacy Solutions and a Senior Partner at Accelera Canada, where he is responsible for Advocacy & Stakeholder Relations.

In this episode of The Pharma Podcast Ryan discusses CADTH (Canadian Agency for Drugs and Technologies in Health)  and the streamlined input processes for both patients and Clinicians.

Contact Information:
ryan.clarke@acceleracanada.com

C: 416.919.9532 
Toll Free: 1.800.250.1569
219 Dufferin Street, Unit 210B, Toronto ON, M6K 3J1

 

]]> http://thepharmapodcast.ca Ryan Clarke Buzzsprout-8039375 Sat, 27 Feb 2021 08:00:00 -0500 1342 CADTH, HTA process, patients, clinicians, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 2 5 full false PMPRB New Guidelines Affecting Drug Pricing in Canada PMPRB New Guidelines Affecting Drug Pricing in Canada On this episode of The Pharma Podcast my guest is Lindy Forte, Senior Partner, Health Technology Assessment at Accelera Canada .

Lindy discusses the Patented Medicines Pricing Review Board (PMPRB),  the amendments to the Patented Medicines Regulations and its impact on Drug prices in Canada.

She also shares her thoughts on what she likes about the new regulations, and some potential shortcomings.

This episode of the podcast is a must listen to for any pharma professional considering launching a new drug in Canada.

Contact Information:
www.acceleracanada.com
lindy.forte@acceleracanada.com

]]> On this episode of The Pharma Podcast my guest is Lindy Forte, Senior Partner, Health Technology Assessment at Accelera Canada .

Lindy discusses the Patented Medicines Pricing Review Board (PMPRB),  the amendments to the Patented Medicines Regulations and its impact on Drug prices in Canada.

She also shares her thoughts on what she likes about the new regulations, and some potential shortcomings.

This episode of the podcast is a must listen to for any pharma professional considering launching a new drug in Canada.

Contact Information:
www.acceleracanada.com
lindy.forte@acceleracanada.com

]]> http://thepharmapodcast.ca Lindy Forte Buzzsprout-7621852 Mon, 01 Feb 2021 21:00:00 -0500 1055 PMPRB, Drug Prices, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 2 4 full false Canadian Attitudes on Healthcare and Telemedicine Canadian Attitudes on Healthcare and Telemedicine In this episode of the PharmaPodcast my guest is Vijay Wadhawan, Vice President, Health and Wellness at Environics Research.   

Getting fast, convenient access to healthcare can be frustrating for many Canadians. COVID19 has exacerbated existing challenges. Telemedicine is a new delivery channel for medicine with the potential to make healthcare more accessible.  

Vijay discusses the findings from a recent survey conducted by Environics Research to understand Canadian attitudes toward healthcare and telemedicine.   

Contact Information for Vijay Wadhawan:
linkedin.com/in/vwadhawan
Vijay.Wadhawan@environics.ca
https://environicsresearch.com/capabilities-insights/health-wellness/

]]> In this episode of the PharmaPodcast my guest is Vijay Wadhawan, Vice President, Health and Wellness at Environics Research.   

Getting fast, convenient access to healthcare can be frustrating for many Canadians. COVID19 has exacerbated existing challenges. Telemedicine is a new delivery channel for medicine with the potential to make healthcare more accessible.  

Vijay discusses the findings from a recent survey conducted by Environics Research to understand Canadian attitudes toward healthcare and telemedicine.   

Contact Information for Vijay Wadhawan:
linkedin.com/in/vwadhawan
Vijay.Wadhawan@environics.ca
https://environicsresearch.com/capabilities-insights/health-wellness/

]]> Sam Tarantino Buzzsprout-6952511 Mon, 21 Dec 2020 13:00:00 -0500 1732 Telemedicine, Digital Heath, Electronic Health Records, EHR, Canada, coronavirus, COVID-19, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medi 2 3 full false Canadian R&D Investment & its Promise in the Wake of COVID-19 Canadian R&D Investment & its Promise in the Wake of COVID-19 In this episode of The Pharma Podcast, my guest is Brian Bloom, co-founder and CEO of Bloom Burton.   

Brian gives us a snap shot of the Canadian R&D landscape, its promise, and how Canadian innovation has been impacted by COVID-19 and how it is contributing to the fight against COVID-19. 

Brian is a true champion of our industry. To bring any new therapy to market requires a good idea, bright minds and a lot of money.   

Brian and his team at Bloom Burton have helped a lot of smart people with bright ideas find the money to fund their dreams and bring new therapies to patients.   

This podcast was  recorded on the heels of the 2020 Bloom Burton Award Gala hosted by Brian and his business partner, and fellow co-founder, Jolyon Burton. The award gala highlights what is possible when we fund smart people with bright ideas. 

]]> In this episode of The Pharma Podcast, my guest is Brian Bloom, co-founder and CEO of Bloom Burton.   

Brian gives us a snap shot of the Canadian R&D landscape, its promise, and how Canadian innovation has been impacted by COVID-19 and how it is contributing to the fight against COVID-19. 

Brian is a true champion of our industry. To bring any new therapy to market requires a good idea, bright minds and a lot of money.   

Brian and his team at Bloom Burton have helped a lot of smart people with bright ideas find the money to fund their dreams and bring new therapies to patients.   

This podcast was  recorded on the heels of the 2020 Bloom Burton Award Gala hosted by Brian and his business partner, and fellow co-founder, Jolyon Burton. The award gala highlights what is possible when we fund smart people with bright ideas. 

]]> http://thepharmapodcast.ca Brian Bloom Buzzsprout-6626776 Mon, 30 Nov 2020 20:00:00 -0500 1343 coronavirus, COVID-19, Canada, Bloom Burton, Brian Bloom, Drug Supply, Pharma, R&D, AbCellera, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 2 2 full false COVID19 Vaccine Distribution in Canada-- Industry Perspective COVID19 Vaccine Distribution in Canada-- Industry Perspective Several COVID19 vaccine candidates are in development and launch plans are being drafted. 

Progress is unfolding at an unprecedented pace. More than 200 potential vaccines are in development and more than 40 have entered human trials.  Applications for approval have  already been submitted to Health Canada under the Interim Order. 

Canada, currently, has access to a guaranteed 174 million doses of potential COVID19 vaccines. This represents over $1 billion in advance purchase agreements  

Canada has also pledged to the World Health Organisation's Advanced Market Commitment (AMC) $220 million to purchase 15 million vaccine doses from the COVAX facility plus $220 million to purchase doses for low- and middle-income countries. 

Securing regulatory approval and supply agreements is a great first step, but how will the vaccine be rolled out safely and  equitable as possible?

To help us understand how industry in Canada is preparing for the roll out, I’ve invited  Daniel Chiasson, President and CEO, of the Canadian Association for Pharmacy Distribution Management (CAPDM). 

]]> Several COVID19 vaccine candidates are in development and launch plans are being drafted. 

Progress is unfolding at an unprecedented pace. More than 200 potential vaccines are in development and more than 40 have entered human trials.  Applications for approval have  already been submitted to Health Canada under the Interim Order. 

Canada, currently, has access to a guaranteed 174 million doses of potential COVID19 vaccines. This represents over $1 billion in advance purchase agreements  

Canada has also pledged to the World Health Organisation's Advanced Market Commitment (AMC) $220 million to purchase 15 million vaccine doses from the COVAX facility plus $220 million to purchase doses for low- and middle-income countries. 

Securing regulatory approval and supply agreements is a great first step, but how will the vaccine be rolled out safely and  equitable as possible?

To help us understand how industry in Canada is preparing for the roll out, I’ve invited  Daniel Chiasson, President and CEO, of the Canadian Association for Pharmacy Distribution Management (CAPDM). 

]]> Sam Tarantino Buzzsprout-5954146 Sun, 18 Oct 2020 21:00:00 -0400 1277 coronavirus, COVID-19, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 2 1 full false Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19 Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19 In this episode of The Pharma Podcast  we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19. 

My guest is Tiana DiMichele, Director, Business Development, Impres Inc.

Contact Information:
Tiana DiMichele, Director, Business Development
Phone: (416) 885-0023 |
E-mail: tianadimichele@imprespharma.ca

]]> In this episode of The Pharma Podcast  we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19. 

My guest is Tiana DiMichele, Director, Business Development, Impres Inc.

Contact Information:
Tiana DiMichele, Director, Business Development
Phone: (416) 885-0023 |
E-mail: tianadimichele@imprespharma.ca

]]> Sam Tarantino Buzzsprout-4356902 Sun, 28 Jun 2020 22:00:00 -0400 1172 coronavirus, COVID-19, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 1 7 full false COVID-19 Financial Resources Available to Canadian Pharma COVID-19 Financial Resources Available to Canadian Pharma In this Episode of The Pharma Podcast  we will discuss the financial resources available to Canadian life science companies facing financial hardship in the wake of the COVID-19 Pandemic. 

My guest is Dan Juskovic, Head, Life Sciences and Health Services, RBC.  

Dan offers sound advice  to help  Life Science Companies in Canada who have been directly impacted by COVID-19 and as a result are facing financial challenges.

Dan can be reached by email at: dan.juskovic@rbc.com

]]> In this Episode of The Pharma Podcast  we will discuss the financial resources available to Canadian life science companies facing financial hardship in the wake of the COVID-19 Pandemic. 

My guest is Dan Juskovic, Head, Life Sciences and Health Services, RBC.  

Dan offers sound advice  to help  Life Science Companies in Canada who have been directly impacted by COVID-19 and as a result are facing financial challenges.

Dan can be reached by email at: dan.juskovic@rbc.com

]]> Dan Juskovic Buzzsprout-3988940 Sun, 31 May 2020 16:00:00 -0400 2056 coronavirus, COVID-19, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 1 6 full false COVID-19 Special Edition – Canadian Access to Future Coronovirus Treatment – Canadian Regulatory Framework COVID-19 Special Edition – Canadian Access to Future Coronovirus Treatment – Canadian Regulatory Framework In this episode I spoke with Nathaniel Lipkus, intellectual property litigator, and partner at Osler, Hoskin & Harcourt LLP.

Nate is a legal expert on patent and regulatory issues facing pharmaceutical and biotechnology companies. 

Nate has also published extensively on topics pertaining to Canada’s Patent Act . Nate  recently wrote an article for the Globe and Mail exploring today’s topic.   

In this episode, Nate provides insight on Canada's regulatory framework and how it can assist Canadian access to new therapeutics to the novel coronavirus.  Specifically, we explore the COVID-19 Emergency Response Act (Bill C-13) and its provisions. 

We also explore Canada’s industrial capability to meet future demand to treatment.

CONTACT INFORMATION

nlipkus@osler.com

]]> In this episode I spoke with Nathaniel Lipkus, intellectual property litigator, and partner at Osler, Hoskin & Harcourt LLP.

Nate is a legal expert on patent and regulatory issues facing pharmaceutical and biotechnology companies. 

Nate has also published extensively on topics pertaining to Canada’s Patent Act . Nate  recently wrote an article for the Globe and Mail exploring today’s topic.   

In this episode, Nate provides insight on Canada's regulatory framework and how it can assist Canadian access to new therapeutics to the novel coronavirus.  Specifically, we explore the COVID-19 Emergency Response Act (Bill C-13) and its provisions. 

We also explore Canada’s industrial capability to meet future demand to treatment.

CONTACT INFORMATION

nlipkus@osler.com

]]> Nathaniel Lipkus, Intellectual Property Litigator, and Partner at Osler, Hoskin & Harcourt LLP in Toronto Buzzsprout-3525169 Mon, 27 Apr 2020 12:00:00 -0400 1870 coronavirus, COVID-19, Canada, Drug Supply, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 1 5 full false Canada's Drug Supply Chain: COVID-19 Special Edition Canada's Drug Supply Chain: COVID-19 Special Edition This is a special edition of The Pharma Podcast.

Daniel Chiasson, President and CEO of the Canadian Association for Pharmacy Distribution Management (CAPDM), provides his insights on “Canada's Drug Supply Chain and how CAPDM and its members are facing the COVID-19 pandemic.

]]> This is a special edition of The Pharma Podcast.

Daniel Chiasson, President and CEO of the Canadian Association for Pharmacy Distribution Management (CAPDM), provides his insights on “Canada's Drug Supply Chain and how CAPDM and its members are facing the COVID-19 pandemic.

]]> Daniel Chiasson, President and CEO of the Canadian Association for Pharmacy Distribution Management (CAPDM) Buzzsprout-3201364 Wed, 01 Apr 2020 12:00:00 -0400 1600 coronavirus, COVID-19, Canada, Drug Supply, CAPDM, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, PMPRB 1 4 full false The Evolving Role of Specialty Pharmacy in Canada. The Evolving Role of Specialty Pharmacy in Canada. Jane Farnham is a recognized thought leader in streamlining the complex processes for patients receiving speciality medications. She has both a professional and personal interest in the rare disease space. 

In this episode, Jane will provide insights on “The evolving role of specialty pharmacy in supporting patients with increasingly complex new therapies in a changing regulatory and reimbursement environment.”

Contact Information:
janefarnham8888@gmail.com.

]]> Jane Farnham is a recognized thought leader in streamlining the complex processes for patients receiving speciality medications. She has both a professional and personal interest in the rare disease space. 

In this episode, Jane will provide insights on “The evolving role of specialty pharmacy in supporting patients with increasingly complex new therapies in a changing regulatory and reimbursement environment.”

Contact Information:
janefarnham8888@gmail.com.

]]> Jane Farnham Buzzsprout-2778691 Tue, 18 Feb 2020 15:00:00 -0500 1655 Specialty Pharmacy, PMPRB, Canada, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 1 3 full false Market Entry in Canada and the Pitfalls to Avoid - a GM's Perspective. Market Entry in Canada and the Pitfalls to Avoid - a GM's Perspective. Accelera Canada is Canada’s premier consulting firm offering end to end advice and services to emerging companies wanting to bring their new medical innovation to Canada.  

Deborah Brown is one of Canada's most experienced General Managers with close to three decades  of industry experience -- both domestic and international.

In this episode, Deb will share her insights on how to optimize one's approach to planning a market entry in Canada and the commercial options that emerge from that analysis - and the pitfalls to avoid!

Contact Information:
www.acceleracanada.com
deborah.brown@acceleracanada.com.

 

]]> Accelera Canada is Canada’s premier consulting firm offering end to end advice and services to emerging companies wanting to bring their new medical innovation to Canada.  

Deborah Brown is one of Canada's most experienced General Managers with close to three decades  of industry experience -- both domestic and international.

In this episode, Deb will share her insights on how to optimize one's approach to planning a market entry in Canada and the commercial options that emerge from that analysis - and the pitfalls to avoid!

Contact Information:
www.acceleracanada.com
deborah.brown@acceleracanada.com.

 

]]> Deborah Brown, Managing Partner, Accelera Canada Buzzsprout-2600581 Tue, 28 Jan 2020 15:00:00 -0500 1943 Accelera, PMPRB, Canada, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana, Drug Establishment Licence 1 2 full false Introduction to the Pharma Podcast Introduction to the Pharma Podcast Introduction to the Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma Biotech and Medtech.

Contact:
starantino@apcipharma.com 



]]> Introduction to the Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma Biotech and Medtech.

Contact:
starantino@apcipharma.com 



]]> Sam Tarantino Buzzsprout-2304377 Tue, 17 Dec 2019 16:00:00 -0500 171 PMPRB, Canada, Pharma, Pharmacare, Drug prices, life sciences, innovative drugs, generic drugs, biologics, biosimilars, vaccines, gene therapy, medtech, medical marijuana 1 1 full false